PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Apr-2024 Dr. Amir Bajoghli Receives Top Doctor Award 2024 in Dermatology by Northern Virginia Magazine AccessWire
24-Apr-2024 Moderna and OpenAI Collaborate To Advance mRNA Medicine AccessWire
24-Apr-2024 Vytalize Health Announces Key Leadership Additions to Support Continued Excellence in Value-Based Care AccessWire
24-Apr-2024 Clearstep Partners with Ochsner Health to Tackle Healthcare Access and Capacity Challenges AccessWire
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update AccessWire
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK AccessWire
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer AccessWire
24-Apr-2024 Senzime publishes annual and sustainability report for 2023 AccessWire
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update CureVac
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK CureVac
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer CureVac
24-Apr-2024 Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission AccessWire
24-Apr-2024 Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement AccessWire
24-Apr-2024 BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene
24-Apr-2024 Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices Chiesi Group
24-Apr-2024 Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium AccessWire
24-Apr-2024 Bone Graft Substitutes Market Future Projections: USD 5.6 Billion By 2033 With A Consistent 6.2% Growth Rate Wired Release
24-Apr-2024 Antiviral Drugs Market Trends Suggest A USD 71.1 Billion Valuation By 2033, With A Projected 3.7% CAGR Wired Release
24-Apr-2024 TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT Tryp Therapeutics Inc.
24-Apr-2024 Tryp Therapeutics Provides Update on Plan of Arrangement With Exopharm Limited and Announces Voluntary Trading Halt AccessWire